Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:00 AM
Ignite Modification Date: 2025-12-26 @ 12:24 AM
NCT ID: NCT01748994
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT01748994
Study Brief: Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Placebo Administration of placebo to upper- and lower-body obese women Placebo None None 0 31 15 31 View
Drug Administration of pioglitazone to upper- and lower-body obese women Pioglitazone: 30mg per day for four months None None 0 32 15 32 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Vertigo (dizziness) NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Skin irritation NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Gastrointestinal issues NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Skin hematoma NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View